The Binding Site & Rockland Immunochemicals Enter Into Distribution Agreement

Share Article

UK based specialist diagnostic manufacturer, The Binding Site Group Ltd, is pleased to announce that it has entered into an exclusive, definitive agreement with Rockland Immunochemicals, Inc., of Limerick, PA, to grant Rockland global distribution rights for Binding Site’s line of animal-focused radial immunodiffusion (RID) test kits.

UK based specialist diagnostic manufacturer, The Binding Site Group Ltd, is pleased to announce that it has entered into an exclusive, definitive agreement with Rockland Immunochemicals, Inc., of Limerick, PA, to grant Rockland global distribution rights for Binding Site’s line of animal-focused radial immunodiffusion (RID) test kits. The availability of this unique range of products exclusively through Rockland will benefit the needs of laboratory professionals conducting basic, applied, and clinical research in the veterinary, biomedical, life-science, genomics, and drug discovery fields.

Radial immunodiffusion is a robust assay used to determine the concentration of an antigen, or protein, in a biological sample. The estimated $75 billion monocolonal antibody market combined with the growing number of biosimilars is driving increased demand for critical testing reagents, kits and assays. The RID Immunoassay kits are easy to use and incorporate monospecific antibodies in an agarose gel, to provide accurate quantitation. Terri Poole, Chief Commercial Officer at Rockland Immunochemicals, Inc., states, “Our customers trust that Rockland will provide the most relevant products for their research. These RID kits are a perfect addition to our constantly expanding product portfolio and will benefit our clientele across the life science industry.”

Julia Nisbet-Fahy, Binding Site’s Global Business Manager for their Immunologicals Group, commenting on the Agreement, remarks; "A proven track record, industry knowledge, and technical expertise in the research market were the primary motivators in our selection of Rockland to adopt and distribute these products. The combined goal of our partnership is to provide customers accurate and reliable products. Binding Site is confident of our joint success."

Binding Site’s Immunologicals Group serves the in-vitro diagnostic (IVD) manufacturing and clinical/life-science research markets with a comprehensive line of innovative products. For additional information, contact The Binding Site, Inc. at 6730 Mesa Ridge Road San Diego, CA 92121 USA. Phone: 800-633-4484; FAX: 858-453-9189; Email: info(at)thebindingsite(dot)com. Please visit our website at http://www.thebindingsite.com.

# # #

TO THE EDITOR:

With its origins in the Medical School of Birmingham University, Binding Site is now one of the largest independent providers of in vitro diagnostic tests and equipment in the industry. Exporting over 90% of its products overseas from the UK, it is the world leader in special protein testing. Today it employs more than 650 people and maintains offices in the United States and Europe, including a manufacturing and research facility, operating under GMP and ISO Quality Standards, located in Birmingham, England. Please refer any requests for additional information directly to:

Ms. Celina Pradis – Marketing Assistant
Binding Site Inc.
6730 Mesa Ridge Road
San Diego, CA 92121 USA
Phone: 800-633-4484
Fax: 858-453-9189
Email: celina.pradis(at)thebindingsite(dot)com

Rockland Immunochemicals, Inc. supports the academic, biopharma, and diagnostic industries with antibodies and antibody based tools used in basic research, assay development, and preclinical studies. With facilities in Pennsylvania for over 50 years, Rockland manufactures products ideally suited for integration into critical assays such as western blotting, immunohistochemistry (IHC), immunofluorescence microscopy (IF), ELISA and flow cytometry. Additional information about Rockland’s life science tools and services can be found on Rockland’s website at http://www.rockland-inc.com.

Dana Dever
Marketing Manager
Rockland Immunochemicals, Inc.
Phone: 484.791.3823
Email: dana.dever(at)rockland-inc(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dana Dever
Rockland Immunochemicals, Inc.
+1 (484) 791-3823 Ext: 1211
Email >
@Rockland_Inc
Follow >
Rockland Immunochemicals for Research
since: 10/2009
Like >
Rockland Immunochemicals Inc.

Follow us on
Visit website